SARS-COV2

Clinical trials for SARS-COV2 explained in plain language.

Never miss a new study

Get alerted when new SARS-COV2 trials appear

Sign up with your email to follow new studies for SARS-COV2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 5 Completed 12 Terminated 1

Can a new drug shield lungs from COVID-19's worst damage?

Disease control Terminated

This trial tests whether an experimental drug called BIO101 can prevent severe breathing problems in hospitalized adults with COVID-19 pneumonia. Participants receive either BIO101 or a placebo for 28 days, and researchers track who develops respiratory failure, needs high-flow o…

Matched conditions: SARS-COV2

Phase: PHASE2, PHASE3 • Sponsor: Biophytis • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC

SARS-COV2

Get alerted when new SARS-COV2 trials appear

Can a new drug shield lungs from COVID-19's worst damage?